News & Updates

Researchers from the Chinese University of Hong Kong (CUHK) have developed a wireless, battery-free, deformable electronic stent (e-stent) for treatment of gastroesophageal reflux disease (GERD), eliminating the need for invasive surgery.

A three-step ablation strategy that systematically targets multiple proarrhythmogenic atrial structures appeared superior to pulmonary vein isolation (PVI) alone in patients with persistent atrial fibrillation (AF), according to 10-month results of a new study presented at EHRA 2023.

Among patients with atrial fibrillation (AF), statin use was associated with a significantly lower risk of stroke or transient ischaemic attack (TIA) compared with non-use, according to a study presented at EHRA 2023.

Poor dietary choices have driven type 2 diabetes (T2D) up to a staggering 14.1 million cases in 2018, accounting for about 70 percent of all new T2D diagnoses around the world, according to a study.

Nearly two in three participants in the placebo arm of nonalcoholic steatohepatitis (NASH) randomized clinical trials (RCTs) experience an adverse event (AE), while one in 10 have a serious AE, according to a pooled analysis of studies with NASH placebo.

Treatment with continuous positive airway pressure (CPAP) for 6 months deters atrial remodeling and improves the possibility of achieving diastolic dysfunction reversibility in patients with metabolic syndrome (MS) and obstructive sleep apnoea (OSA), a study has shown.